Press releases.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014

Jun 30, 2025

News

IR

English

Corporate Information

Other Corporate Information

mfn-ext-nq

mfn-ext-nq-company-announcement

SenzaGen obtains expanded OECD approval for GARD®skin – further strengthens position in non-animal regulatory testing

Jun 24, 2025

News

IR

English

Corporate Information

Other Corporate Information

mfn-ext-nq

mfn-ext-nq-company-announcement

SenzaGen receives new assignment worth 1.5 MSEK from RIFM for continued collaboration in photosensitization testing

Jun 02, 2025

News

IR

English

Corporate Information

Other Corporate Information

mfn-ext-nq

mfn-ext-nq-company-announcement

SenzaGen receives new assignment from RIFM – confirms successful expansion of testing portfolio

May 14, 2025

News

IR

English

Regulatory

Listing Regulation

Corporate Information

General meeting

Report of the AGM

Report from AGM of SenzaGen AB on 14 May 2025

May 14, 2025

News

IR

English

Regulatory

MAR

Report

Interim

Q1

SenzaGen’s interim report January–March 2025: High activity amid global turbulence – building for growth

May 08, 2025

News

IR

English

Corporate Information

Other Corporate Information

mfn-ext-nq

mfn-ext-nq-company-announcement

Invitation to the presentation of SenzaGen's January-March 2025 interim report

Apr 22, 2025

News

IR

English

Corporate Information

Other Corporate Information

FDA signals shift towards non-animal testing in the pharmaceutical industry – strengthens SenzaGen’s commercial potential

Apr 11, 2025

News

IR

English

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

Notice of Annual General Meeting of SenzaGen AB (publ)

Apr 11, 2025

News

IR

English

Regulatory

Listing Regulation

Report

Annual

SenzaGen’s Annual Report 2024 published

Apr 10, 2025

News

IR

English

Corporate Information

Sales

Order

SenzaGen expands regulatory testing portfolio – strengthens competitiveness and secures new orders

Feb 13, 2025

News

IR

English

Regulatory

MAR

Report

Interim

Yearend

GARD® going stronger and subsidiary enters new phase

Feb 06, 2025

News

IR

English

Corporate Information

Other Corporate Information

Invitation to the presentation of SenzaGen's year-end report 2024 on Feb 13 at 12.00

Nov 08, 2024

News

IR

English

Regulatory

MAR

Report

Interim

Q3

SenzaGen’s interim report January–September 2024: Strong quarter with over 30% growth

Sep 10, 2024

News

IR

English

Corporate Information

Sales

Order

SenzaGen and RIFM advance collaboration in non-animal photosensitization testing – new grant worth SEK 3.0m

Aug 22, 2024

News

IR

English

Regulatory

MAR

Report

Interim

Q2

SenzaGen’s interim report January–June 2024: 30% growth in Q2, and funding secured for new commercial growth projects

Aug 21, 2024

News

IR

English

Corporate Information

Other Corporate Information

SenzaGen expands its market presence in the USA with licensing agreement with IIVS

Aug 15, 2024

News

IR

English

Corporate Information

Presentation

Invitation to the presentation of SenzaGen's Interim Report January–June 2024

Aug 12, 2024

News

IR

English

Corporate Information

Sales

Order

SenzaGen secures 1.3 MSEK order for GARD®skin Dose-Response from leading global chemical company

Jul 03, 2024

News

IR

English

Corporate Information

Sales

Order

SenzaGen extends collaboration with RIFM for non-animal testing – secures new 1.5 MSEK grant

Jun 12, 2024

News

IR

English

Regulatory

MAR

Corporate Action

Shares

Issuance

SenzaGen has carried out a directed share issue of approximately SEK 37.2 million

Subscribe

English

Swedish

Reports

Press releases

Prenumerera